Leeds Healthtech Startup Secures £10 Million Series A to Scale AI-Powered Medical Device Simulation Platform

Leeds‑based spinout adsilico secured £10 million in Series A funding led by PXN Ventures to scale its generative‑AI platform that creates virtual patient models, helping medical‑device makers test implants such as heart valves and stents before clinical trials.

FSE Group launches £70 million debt fund to support London scale-ups locked out of traditional finance

The FSE Group announced the Future London Growth Fund, a new debt vehicle of more than £70 million backed by the British Business Bank and Funding London, aimed at supporting high‑growth scale‑ups in London’s 32 boroughs that struggle to access conventional financing.

Irish LegalTech Startup EstateMin Secures €1 Million to Expand AI Platform Across US

Irish‑founded LegalTech startup EstateMin secured €1 million in pre‑Seed financing from NDRC, First Port Syndicate, Enterprise Ireland and several angels. The round will fund its US expansion, hiring, and go‑to‑market efforts. The AI‑driven platform digitises estate‑law client intake and currently supports over €686 million in estate values across 777 matters in all 50 US states.

London Surgical AI Startup XRlabs Raises €7.48 Million in Seed Round

London‑based XRlabs, a surgical intelligence startup founded by neurosurgeon Dr. Ali Haddad in 2024, secured €7.48 million in Seed funding led by Playground Global with participation from Eka Ventures. The round will help the company expand its engineering and clinical teams and push its AI‑driven surgical platform through regulatory approvals across Europe and the US.

Bristol MedTech Startup Siloton Secures €9.98 Million Innovate UK Contract for Portable Eye Imaging System

Bristol‑based MedTech startup Siloton secured a €9.98 million Innovate UK contract to fast‑track its portable optical coherence tomography (OCT) eye‑imaging system, aiming to make retinal disease detection more accessible in clinics, community settings and homes while creating high‑skill jobs and preparing for further investment.

Oxford Biotech OMass Therapeutics Secures €275 Million Series C to Advance Small-Molecule Pipeline

Oxford spin‑out OMass Therapeutics raised €275 million in a Series C round co‑led by Bain Capital Life Sciences, Forbion and Novo Holdings to push its novel small‑molecule therapies, including OMS1620 for congenital adrenal hyperplasia, into the clinic.